Skip to content

Importance of patient reported outcomes in choice of therapy for mamma patients

Importance of patient reported outcomes in choice of therapy for mamma patients - IMPACT-study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38173
Enrollment
650
Registered
2013-12-11
Start date
2013-07-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastcancer malignant tumor breast

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 18 years or older - Underwent surgery for breastcancer between 9 and 18 months ago

Exclusion criteria

Exclusion criteria: - Metastatic disease

Design outcomes

Primary

MeasureTime frame
An overview of the more en less important outcomes after treatment of breast cancer in the opinion of patients.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)